Democrats will fight tooth and nail to save Obamacare, but given the flaws in the plan, they are not likely to succeed. Obamacare in its current form is the walking dead. Trump has said that he will replace Obamacare with something better. In his speeches, Trump outlined certain key points
It is official: India is siding with poor cancer patients over profits for multinational drug giants. The Supreme Court of India has rejected a plea by Swiss pharma giant Novartis that ends the seven-year legal battle to restrict Indian companies from copying blood cancer drug Glivec. Novartis had filed a plea with the Supreme
Obama has been re-elected; “Obamacare” is the law of the land. It doesn’t matter if you agree or disagree with Obamacare, you might as well generate big profits from it. Obamacare has been profitable for us. We bought Amerigroup Corp. AGP at $22.05, and, as of this writing, the stock
A popular axiom among long-only investors is to “buy low sell high.” For those investors who are equally interested in making money from both markets going up and markets going down, the parallel axiom is, “short-sell high and buy-to-cover low.” In the short-term, the stock market is overbought, and it
In 1971, a Japanese biochemist, Akira Endo, started work on what turned out to be the next big thing in the prevention of heart attacks and strokes, known as statins. In 1978, Merck (MRK) isolated lovastatin from fungusAspergillus terreus. Lovastatin is naturally contained in red yeast rice, a traditional Chinese fermented rice
Our methodology correctly predicted conditions at MRK as is evidenced by its earnings this morning. Consider start taking partial profits in $23.00 to $23.20 range or higher, depending on the size of your position. If the stock falls further consider to continue to take profits. www.thearorareport.com THE ARORA REPORT, Ltd.
Merck had the best two day gain ever in its history. After a 38% gain, this afternoon smart money was selling in the wake of massive short covering as measured by our proprietary studies. The initial trigger to the upside today was an analyst upgrade. Nothing fundamental has changed in